Our findings reveal critical flaws in the current FDA device review system and its implementation that will require either congressional action or major changes in regulatory policy," wrote Diana M. Zuckerman of the National Research Center for Women & Families in Washington, D.C., and Steven E. Nissen of the Cleveland Clinic in Cleveland.
Friday, February 18, 2011
Study of recalled medical devices faults lax FDA testing methods
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment